Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles
about
Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domainsIFITM3 inhibits influenza A virus infection by preventing cytosolic entryCellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomesMechanisms of viral entry: sneaking in the front doorEntry of pseudotyped hepatitis C virus into primary human hepatocytes depends on the scavenger class B type I receptorThe tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virusIntramembrane processing by signal peptide peptidase regulates the membrane localization of hepatitis C virus core protein and viral propagationScavenger receptor BI and BII expression levels modulate hepatitis C virus infectivityRab 5 is required for the cellular entry of dengue and West Nile virusesEntry inhibitors: New advances in HCV treatmentHepatitis C virus comes for dinner: How the hepatitis C virus interferes with autophagyGenetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine DesignNew hepatitis C virus drug discovery strategies and model systemsThe hepatitis C virus glycan shield and evasion of the humoral immune responseIntracellular Transport of Vaccinia Virus in HeLa Cells Requires WASH-VPEF/FAM21-Retromer Complexes and Recycling Molecules Rab11 and Rab22.Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoproteinMolecular determinants and dynamics of hepatitis C virus secretionReplication-Competent Recombinant Vesicular Stomatitis Virus Encoding Hepatitis C Virus Envelope ProteinsStudying Hepatitis C Virus: Making the Best of a Bad VirusCorrelation of the Tight Junction-like Distribution of Claudin-1 to the Cellular Tropism of Hepatitis C VirusDirect Infection and Replication of Naturally Occurring Hepatitis C Virus Genotypes 1, 2, 3 and 4 in Normal Human Hepatocyte CulturesCD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human HepatocytesIdentification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing AntibodiesHepatitis C Virus Is a Weak Inducer of Interferon Alpha in Plasmacytoid Dendritic Cells in Comparison with Influenza and Human Herpesvirus Type-1Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replicationInitiation of Hepatitis C Virus Infection Requires the Dynamic Microtubule Network: ROLE OF THE VIRAL NUCLEOCAPSID PROTEINResidues in a Highly Conserved Claudin-1 Motif Are Required for Hepatitis C Virus Entry and Mediate the Formation of Cell-Cell ContactsThe Tight Junction-Associated Protein Occludin Is Required for a Postbinding Step in Hepatitis C Virus Entry and InfectionLow pH-dependent Hepatitis C Virus Membrane Fusion Depends on E2 Integrity, Target Lipid Composition, and Density of Virus ParticlesA Functional Genomic Screen Identifies Cellular Cofactors of Hepatitis C Virus ReplicationHepatoma Cell Density Promotes Claudin-1 and Scavenger Receptor BI Expression and Hepatitis C Virus InternalizationRNA Interference and Single Particle Tracking Analysis of Hepatitis C Virus EndocytosisIdentification of GBF1 as a Cellular Factor Required for Hepatitis C Virus RNA ReplicationMouse-Specific Residues of Claudin-1 Limit Hepatitis C Virus Genotype 2a Infection in a Human Hepatocyte Cell LineEndocytic Rab proteins are required for hepatitis C virus replication complex formationCrystal structure of glycoprotein E2 from bovine viral diarrhea virusFusion of Enveloped Viruses in Endosomes.Comparative Proteomics Reveals Important Viral-Host Interactions in HCV-Infected Human Liver CellsA novel small molecule inhibitor of hepatitis C virus entryMechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol
P2860
Q21089621-D4BE8B15-B87F-42BB-9C39-AFFA08434A66Q21090493-252BB850-5B6B-4D2A-BDF6-F66AD0A6292BQ21131434-610F7DD1-30E0-4C12-9B5C-5DCB16DA9138Q22252690-1014A079-F51E-4BC0-9643-79BD8B7990AFQ24336433-5F4BB5BC-8F07-4DEC-B049-434FD9A79C64Q24652906-C86BF4CC-CD72-4E45-AD00-FC37468A4673Q24658154-D2F33DA1-80B1-4116-8CDD-6E453B39BE31Q24672232-9463E434-12E9-4294-8235-274FC706AC36Q24683001-5D48926C-3636-41A2-9FC8-6BEECDA77302Q26770817-86E57EB5-55D3-49B5-AC0F-64590F5DB35BQ26801207-60301F99-6B24-4CDB-9E8E-78E6056F017AQ26801759-38FA1DBA-1E87-4DBA-B4DF-5E31C1C48C89Q26851159-A63844F6-D7EC-4908-AE06-D0186FA2B133Q27023390-1C33D8AF-DCF6-4FD6-9737-DC4ABB63FA38Q27321587-E90CFB37-717D-4D6C-B67B-2706B5D91CF0Q27333881-CB71331A-ADC2-40BE-8789-2F4B88EA9995Q27347838-36D75E36-2A7B-4CE9-B2DF-00400B6A7E61Q27481021-70B77A6E-7C6D-4582-9760-8C180471FC96Q27481034-D42D141E-3382-433E-82CB-147ED7D3DB07Q27486250-23050C51-B651-4AE9-A982-AAB8111E629DQ27486394-9212F239-7708-4698-801D-BD4F68D7D9E1Q27486789-37D0D8E9-4010-42A6-BFB0-8C9DC70E1E47Q27487399-24620A7B-50FE-49DE-94DD-A666A3AEC8E0Q27487765-E8B744C3-EAD9-43B4-9804-6C26DCE2229DQ27488365-6E4F201D-BBC9-4D7B-B08A-989997EA8813Q27488371-23A67F3D-953E-4775-BB98-FB5F1540C493Q27488396-FB402DDF-6095-4FCE-ABC9-C2736D6F0B3DQ27488990-1568C133-ACA0-4EA4-9786-A18F307124D9Q27489056-A3B7CD77-AA6B-4509-88C7-D9AFDC2D7BDBQ27489843-ED8D53C8-71E1-46EB-9776-B683BB58F82BQ27490466-E520CA11-9A4A-424D-9D05-62E7BD4BB3D5Q27490501-83B1899A-7D69-4F44-B4EB-231D9B1981D0Q27490525-72E8BCC0-CA8C-4672-8E1A-7EFDD43844A2Q27490526-0A9231D9-79DB-4C18-B635-5397B1B0AB72Q27490939-AEC1E98A-1A84-4902-95F3-01CB7CADB0FAQ27677276-A84265E4-41AB-4D65-8770-F9547933F2E2Q28073406-64D51AA7-378D-4BA4-82D7-3C642742CAB2Q28115022-2EEF4F55-F04A-4946-B816-76A966CE66C8Q28475468-D00A625D-1D43-407E-B3DE-13A0CD4F14E1Q28476811-6CC761E2-948B-424C-A2E5-876C5ECFC6DF
P2860
Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Hepatitis C Virus Entry Requir ...... s via Clathrin-Coated Vesicles
@ast
Hepatitis C Virus Entry Requir ...... s via Clathrin-Coated Vesicles
@en
Hepatitis C Virus Entry Requir ...... s via Clathrin-Coated Vesicles
@nl
type
label
Hepatitis C Virus Entry Requir ...... s via Clathrin-Coated Vesicles
@ast
Hepatitis C Virus Entry Requir ...... s via Clathrin-Coated Vesicles
@en
Hepatitis C Virus Entry Requir ...... s via Clathrin-Coated Vesicles
@nl
prefLabel
Hepatitis C Virus Entry Requir ...... s via Clathrin-Coated Vesicles
@ast
Hepatitis C Virus Entry Requir ...... s via Clathrin-Coated Vesicles
@en
Hepatitis C Virus Entry Requir ...... s via Clathrin-Coated Vesicles
@nl
P2860
P3181
P356
P1433
P1476
Hepatitis C Virus Entry Requir ...... s via Clathrin-Coated Vesicles
@en
P2093
Claire Bertaux
Tatjana Dragic
P2860
P304
P3181
P356
10.1128/JVI.01717-06
P577
2006-12-01T00:00:00Z